Instructions for Formisonide (Budesonide, Formoterol) powder with an inhaler
English Product Name
Formisonid
Dosage form
powder d / inhalation metered 80 μg + 4.5 μg / 1 caps.: 30, 60 or 120 pcs.
powder d / inhalation metered 160 μg + 4.5 μg / 1 caps.: 30, 60 or 120 pcs.
powder d / inhalation dosed 320 μg + 9 μg / 1 caps.: 30, 60 or 120 pcs.
Description Formisonide:
Powder for inhalation dosed in hard capsules, No3, transparent, light brown color; the contents of the capsules are white or almost white powder.
1 caps.
budesonide 80 mcg
formoterol fumarate dihydrate 4.5 mcg
Excipients:
sodium benzoate - 0.02 mg,
lactose monohydrate - up to 12 mg.
Composition of the capsule shell:
dye "caramel" - 1.4388%,
hypromellose - up to 100%.
Excipients Budesonide:
sodium benzoate - 0.02 mg,
lactose monohydrate - up to 12 mg.
Composition of the capsule shell:
dye "caramel" - 1.4388%,
hypromellose - up to 100%.
ATX Codes Formisonide
R03AK07 Formoterol and Budesonide
Clinical and pharmacological groups / Group affiliation
The drug with anti-inflammatory and bronchodilator action
Active ingredient Budesonide
- budesonide
- formoterol fumarate dihydrate
Pharmaco-therapeutic group Formisonide:
Combined bronchodilating agent (selective beta2-adrenomimetic + topical glucocorticosteroid)
Testimony Budesonide:
- Bronchial asthma, insufficiently controlled by taking inhaled GCS and short-acting beta2-adrenergic stimulants or
- adequately controlled by inhaled GCS and long-acting beta2-adrenergic stimulants.
- Symptomatic therapy of patients with severe COPD (FEV1 <50% of the estimated estimated level) and with a history of
- recurring exacerbations who have severe symptoms of the disease,
- despite therapy with long-acting bronchodilators.
Dosage, Course and Dosage Formisonide:
The dose and frequency of use are established individually, depending on the indications, clinical situation, age of the patient, the dosage form used.
Use in elderly patients
There is no need for a special selection of the dose of the drug for elderly patients.
Use in children
The drug is contraindicated for use in children and adolescents under the age of 18 years
- Nosology (ICD codes)
- J44
- Another chronic obstructive pulmonary disease
- J45
- Asthma
pharmachologic effect Formisonide:
Combined bronchodilator. Budesonide and formoterol have different mechanisms of action and exhibit an additive effect in reducing the frequency of exacerbations of bronchial asthma and COPD.
The special properties of budesonide and formoterol make it possible to use their combination simultaneously as maintenance therapy and for the relief of seizures, or as a supportive therapy for bronchial asthma.
